SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
16.04.18 | Roche overweight | JP Morgan Chase & Co. | |
13.04.18 | Roche buy | Jefferies & Company Inc. | |
13.04.18 | Novartis buy | Jefferies & Company Inc. | |
13.04.18 | Roche overweight | JP Morgan Chase & Co. | |
12.04.18 | Novartis Neutral | JP Morgan Chase & Co. | |
12.04.18 | Novartis Hold | Deutsche Bank AG | |
11.04.18 | Novartis buy | HSBC | |
11.04.18 | Novartis Underweight | Barclays Capital | |
10.04.18 | Novartis Underperform | Credit Suisse Group | |
10.04.18 | Novartis Hold | Deutsche Bank AG | |
09.04.18 | Novartis buy | S&P Capital IQ | |
09.04.18 | Novartis Outperform | Bernstein Research | |
09.04.18 | Novartis Halten | Independent Research GmbH | |
09.04.18 | Novartis Neutral | UBS AG | |
09.04.18 | Novartis Neutral | JP Morgan Chase & Co. | |
09.04.18 | Novartis buy | Baader Bank | |
03.04.18 | Roche overweight | JP Morgan Chase & Co. | |
29.03.18 | Roche Hold | Deutsche Bank AG | |
28.03.18 | Novartis buy | Oddo Seydler Bank AG | |
28.03.18 | Novartis Hold | Deutsche Bank AG | |
27.03.18 | Novartis buy | S&P Capital IQ | |
27.03.18 | Novartis buy | Baader Bank | |
27.03.18 | Novartis Neutral | UBS AG | |
27.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
27.03.18 | Roche overweight | JP Morgan Chase & Co. | |
27.03.18 | Roche Underweight | Morgan Stanley | |
23.03.18 | Roche buy | Jefferies & Company Inc. | |
21.03.18 | Roche Hold | Deutsche Bank AG | |
20.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
20.03.18 | Roche Neutral | UBS AG | |
20.03.18 | Roche overweight | JP Morgan Chase & Co. | |
14.03.18 | Novartis buy | Société Générale Group S.A. (SG) | |
14.03.18 | Roche Sell | Société Générale Group S.A. (SG) | |
02.03.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
02.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
01.03.18 | Novartis Neutral | UBS AG | |
26.02.18 | Novartis buy | Jefferies & Company Inc. | |
26.02.18 | Roche buy | Jefferies & Company Inc. | |
22.02.18 | Novartis buy | Société Générale Group S.A. (SG) | |
20.02.18 | Novartis Underweight | Barclays Capital |